Today: 23 April 2026
Experian share price rises after fresh buyback update as investors eye May results
17 February 2026
1 min read

Experian share price rises after fresh buyback update as investors eye May results

London, Feb 17, 2026, 08:23 (GMT) — Regular session

Experian PLC bounced back from a brief early slide, with shares up around 2.2% at 2,525 pence as of 0823 GMT. The latest buyback announcement from the credit data and analytics firm had investors recalibrating.

FTSE 100-listed firm disclosed it bought back 400,000 shares on Feb. 16 via J.P. Morgan Securities, shelling out a weighted average 2,509.9391 pence per share. The company uses buybacks like this to return capital to shareholders and trim its share count.

That buy forms part of Experian’s $1 billion share repurchase plan rolled out Jan. 30, the day the company reiterated no change to its medium-term financial framework, dividend policy or capital allocation. Buybacks like these have turned into a go-to signal for strong cash flows—especially now, with investors quick to punish on price.

The stock’s been volatile lately. Monday saw a 2.6% drop, despite the FTSE 100 ticking higher. It’s still trading roughly 40% under its 52-week peak of 41.01 pounds from July 18, according to MarketWatch data.

Chief Executive Brian Cassin, in the January trading update, said the group “delivered strong Q3 growth,” with full-year expectations sticking where they were. Experian

Traders have their eye on whether demand for credit checks and fraud detection sticks as lenders tweak underwriting and consumers face pressure from rates and employment. Since Experian reports in U.S. dollars, currency swings may show up in its headline growth.

Squeezing the share count with buybacks can push earnings per share higher. Still, they don’t solve sluggish lending or softer demand for data by themselves.

The risk is clear enough: if credit activity slows or delinquencies pick up faster than expected, usage-driven revenue takes a hit. Stricter regulations on consumer data might also limit how the firm puts its datasets to work. When that happens, investors usually shift their attention right back to growth and pricing power.

Experian is set to release its preliminary full-year numbers on May 20, then follows up with a first-quarter trading update slated for July 16.

Stock Market Today

  • Jim Cramer Eyes More Procter & Gamble Shares If Price Dips Below $140
    April 23, 2026, 1:10 PM EDT. On Thursday, Jim Cramer highlighted a market rotation from software to hardware as ServiceNow shares fell 17% post-earnings despite beating forecasts. Chip designer Arm led the hardware rally, surging 6% to record highs, though Cramer expressed concern over its CEO's expanded role at SoftBank. Investor attention turns to Procter & Gamble, which rose over 1% ahead of Friday's earnings. Cramer said he plans to "buy more" shares if the price falls below $140, praising new CEO Shailesh Jejurikar's international expertise. Analysts expect modest earnings per share growth near 1% and organic revenue growth below 2%, with eyes on cost pressures from higher resin prices, a packaging material derived from oil.

Latest article

IREN Stock Jumps as AI Cloud Bet Meets $6 Billion Dilution Test

IREN Stock Jumps as AI Cloud Bet Meets $6 Billion Dilution Test

23 April 2026
IREN shares jumped 7.3% to $51.94 in New York Thursday amid debate over its shift from bitcoin mining to AI cloud services. The company plans to deploy 150,000 Nvidia GPUs by late 2026 and reported $2.8 billion in cash as of January. AI cloud revenue remains small compared to bitcoin mining, with $17.3 million last quarter. IREN can sell up to $6 billion in stock under a new SEC filing.
Hims Adds Lilly’s Zepbound and Foundayo as GLP-1 Price Fight Moves Online

Hims Adds Lilly’s Zepbound and Foundayo as GLP-1 Price Fight Moves Online

23 April 2026
Hims & Hers Health said Thursday its providers can now send prescriptions for Eli Lilly’s Zepbound and Foundayo to LillyDirect, expanding branded obesity drug options on its platform. The move follows a similar deal with Novo Nordisk in March. Hims listed Foundayo from $149 a month and Zepbound from $299. The company previously stopped advertising compounded GLP-1s amid tighter U.S. regulations.
Warren Buffett Successor Greg Abel Tightens Grip on Berkshire Hathaway Portfolio, Pushes New Money Into Japan

Warren Buffett Successor Greg Abel Tightens Grip on Berkshire Hathaway Portfolio, Pushes New Money Into Japan

23 April 2026
Greg Abel now controls about 94% of Berkshire Hathaway’s $300 billion stock portfolio after Todd Combs’ departure, consolidating authority more than Warren Buffett had planned. Abel has kept major U.S. holdings largely intact but increased investments in Japanese firms, including a new $1.8 billion stake in Tokio Marine. Recent portfolio trims, such as Apple and Amazon, reflect Buffett’s last quarter in charge.
Rio Tinto stock in focus before London open as results near after Simandou death
Previous Story

Rio Tinto stock in focus before London open as results near after Simandou death

Northern Star shares tick up with gold stocks as traders eye US inflation data
Next Story

Northern Star shares tick up with gold stocks as traders eye US inflation data

Go toTop